Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.7K
Mutations01:39

Mutations

94.4K
Overview
94.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Viral Mutations00:36

Viral Mutations

39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K
RNA Interference01:23

RNA Interference

27.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.9K
Alternative RNA Splicing02:18

Alternative RNA Splicing

24.8K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute amyloid-β exposure disrupts insulin signaling in hCMEC/D3 blood-brain barrier endothelial cells.

Fluids and barriers of the CNS·2026
Same author

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.

Journal for immunotherapy of cancer·2026
Same author

Landscape of circular RNAs in acute myeloid leukemia and their clinical significance.

NPJ precision oncology·2026
Same author

Bridging the computational-experimental gap: leveraging large language model to prioritize Alzheimer's therapeutics based on comparison of learning models.

npj health systems·2026
Same author

Leveraging multi-source data to resolve inconsistency across pharmacogenomic datasets in drug sensitivity prediction.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Multimodal learning for scalable representation of high-dimensional medical data.

Frontiers in digital health·2026
Same journal

MCFST: Spatial domain identification method based on multi-view graph convolutional network and graph fusion network.

Bioinformatics (Oxford, England)·2026
Same journal

SpaBiT: Enhancing Spatial Transcriptomics Resolution via Bidirectional Attention Transformers.

Bioinformatics (Oxford, England)·2026
Same journal

EDEL: Enhancing Dense Retrievers for Curation of Biomedical Knowledge Bases.

Bioinformatics (Oxford, England)·2026
Same journal

Informative Relational Learning for Adverse Reaction Prediction with Enhanced Generalization to Novel Drugs.

Bioinformatics (Oxford, England)·2026
Same journal

An interpretable deep learning framework uncovers features governing CRISPR-Cas9 genome-editing efficiency.

Bioinformatics (Oxford, England)·2026
Same journal

3DICE: Interpretable 3D Cross-Modal Learning for Drug-Target Interaction Prediction and Large-Scale Drug Discovery.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K

Cell-level somatic mutation detection from single-cell RNA sequencing.

Trung Nghia Vu1, Ha-Nam Nguyen2, Stefano Calza3

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.

Bioinformatics (Oxford, England)
|April 28, 2019
PubMed
Summary
This summary is machine-generated.

We developed SCmut, a novel statistical method for detecting cell-level mutations from single-cell RNA sequencing (scRNA-seq) data. SCmut accurately identifies mutations, overcoming challenges associated with scRNA-seq data quality and enabling deeper insights into cell-to-cell heterogeneity.

More Related Videos

Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

12.1K
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

12.4K

Related Experiment Videos

Last Updated: Jan 25, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K
Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

12.1K
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

12.4K

Area of Science:

  • Genomics
  • Computational Biology
  • Cancer Research

Background:

  • Single-cell sequencing technologies like scRNA-seq and scDNA-seq offer valuable cell-level genomic profiling.
  • Detecting mutations from scRNA-seq data is challenging due to limited input material and amplification biases, unlike scDNA-seq.
  • Existing mutation detection methods for bulk or scDNA-seq data perform poorly on scRNA-seq data, yielding many false positives.

Purpose of the Study:

  • To develop a robust statistical method for accurate cell-level mutation detection using scRNA-seq data.
  • To address the limitations of existing mutation detection tools when applied to scRNA-seq.
  • To enable the investigation of cell-to-cell heterogeneity through precise mutation identification.

Main Methods:

  • Development of SCmut, a novel statistical method for identifying specific cells harboring mutations from bulk-cell data.
  • Implementation of a 2D local false discovery rate method within SCmut for robust false positive control.
  • Application and validation of SCmut on multiple scRNA-seq datasets, including breast cancer and glioblastoma.

Main Results:

  • SCmut successfully identifies highly confident cell-level mutations from scRNA-seq data, showing recurrence across many cells and consistency between samples.
  • In breast cancer scRNA-seq datasets, SCmut detected recurrent cell-level mutations.
  • In a glioblastoma scRNA-seq dataset, SCmut discovered a recurrent mutation in the PDGFRA gene, correlated with a known deletion.

Conclusions:

  • SCmut provides a novel and effective approach for discovering cell-level mutation information from scRNA-seq data.
  • This method facilitates the investigation of cell-to-cell heterogeneity by accurately identifying mutations at the single-cell level.
  • The developed bioinformatics pipeline and source code are publicly available for broader research application.